Search Results 581-590 of 24214 for In situ
Exceptions are non-metastatic basal cell or squamous cell carcinomas of the skin or prostate cancer or in situ cancer that does not require treatment or is well ...
Participants with fully resected Stage 0 (carcinoma in situ) or Stage 1 tumor without signs of recurrence may participate. All other individuals with ...
... in situ, those who received curative treatment and are in complete remission for 5 years, or if the subject is confirmed as cancer free) 25. Known active ...
The main objectives of this study are to determine the difference in change from baseline in ... in situ carcinoma of uterine cervix. Patients who must or wish to ...
History of another primary cancer within the last 3 years with the exception of non-melanoma skin cancer or curatively-treated cervical cancer in-situ.
Adequately treated carcinoma in situ without evidence of disease. History of leptomeningeal carcinomatosis. History of active primary immunodeficiency ...
... in NRSPMS and on ... situ of the cervix or adequately treated non ... in the opinion of the Investigator, contraindicates participation in the study.
in a nonmedication study which, in the opinion of the Investigator, would interfere ... confirmed pre-malignant condition (e.g., ductal carcinoma in situ, colonic ...
... in-situ of the cervix; NOTE: If there is a history or prior malignancy, they must not be receiving other specific treatment (e.g., maintenance or adjuvant ...
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors ... in situ cervical and/or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.